Fred Hutchinson Cancer Center
Clinical trials sponsored by Fred Hutchinson Cancer Center, explained in plain language.
-
New study explores supportive care to help frail patients live better after stem cell transplant
Disease control TerminatedThis study tested two approaches—supportive and palliative care (focusing on symptom relief) and clinical management of other health problems (like heart or lung disease)—to see if they could improve quality of life and survival after a donor stem cell transplant. It included 458…
Phase: PHASE2, PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 22:37 UTC
-
New hope for blood cancer patients: study tests safer transplant drug combo
Disease control TerminatedThis study looked at people with blood cancers receiving a stem cell transplant from an unrelated donor. The goal was to find the best drug combination to prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. Researchers com…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
Can an antiviral drug help ICU patients breathe easier?
Prevention TerminatedThis study tested whether the antiviral drug ganciclovir could prevent the reactivation of cytomegalovirus (CMV) in adults with sepsis and acute respiratory failure in the ICU. The goal was to see if the drug could increase the number of days patients were free from breathing sup…
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jun 01, 2026 18:06 UTC